Avoid IV Labetalol in patients with known hypersensitivity to Labetalol or its components. Monitor for allergic reactions, including bronchospasm.
Exercise caution in patients with pre-existing bradycardia or heart block. Closely monitor heart rate and rhythm. Adjust dosage as needed.
Use with extreme care in patients with severe hepatic impairment or severe bronchial asthma. Reduced metabolism can lead to drug accumulation. Consider alternative agents.
Severe Cardiovascular Conditions
Administer cautiously in patients with severe congestive heart failure, cardiogenic shock, or pheochromocytoma. These conditions may be exacerbated by Labetalol’s effects. Close monitoring is critical.
Monitoring Parameters
Continuously monitor blood pressure, heart rate, and rhythm during IV Labetalol administration. Observe for any signs of hypotension or bradycardia. Regularly assess respiratory function, particularly in asthmatic patients.
Drug Interactions
Labetalol may interact with several medications, including other antihypertensives, beta-blockers, and calcium channel blockers. Closely monitor patients receiving concomitant medications.
Specific Considerations
| Pregnancy | Use only if clearly needed; weigh benefits against potential fetal risks. |
| Breastfeeding | Labetalol is excreted in breast milk; monitor infant for any adverse effects. |
| Renal Impairment | Adjust dosage based on creatinine clearance. |
Overdose
In case of overdose, manage symptoms supportively. Consider administering glucagon for beta-blocker-induced bradycardia or hypotension.
